Windlas Biotech Ltd
NSE:WINDLAS

Watchlist Manager
Windlas Biotech Ltd Logo
Windlas Biotech Ltd
NSE:WINDLAS
Watchlist
Price: 760.25 INR -3.07% Market Closed
Market Cap: 16B INR
Section:
 

Relative Value

The Relative Value of one WINDLAS stock under the Base Case scenario is hidden INR. Compared to the current market price of 760.25 INR, Windlas Biotech Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

WINDLAS Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

1.9
P/S
P/S
Price to Sales
1.9
vs History
41
vs Industry
57
Median 3Y
2
Median 5Y
1.7
Industry
4
More Details
23.7
P/E
P/E
Price to Earnings
23.7
vs History
40
vs Industry
20
Median 3Y
24.5
Median 5Y
19.3
Industry
31.9
More Details
16.9
P/OCF
P/OCF
Price to OCF
16.9
vs History
29
vs Industry
22
Median 3Y
14.1
Median 5Y
10.3
Industry
19.6
More Details
32
P/FCFE
P/FCFE
Price to FCFE
32
vs History
40
vs Industry
8
Median 3Y
39.2
Median 5Y
16.8
Industry
26.9
More Details
3
P/B
P/B
Price to Book Value
3
vs History
34
vs Industry
23
Median 3Y
3.1
Median 5Y
2.1
Industry
2.8
More Details
1.6
EV/S
EV/S
Enterprise Value to Sales
1.6
vs History
40
vs Industry
55
Median 3Y
1.7
Median 5Y
1.4
Industry
4
More Details
4.2
EV/GP
EV/GP
Enterprise Value to Gross Profit
4.2
vs History
40
vs Industry
50
Median 3Y
4.5
Median 5Y
3.7
Industry
8.9
More Details
12.7
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
12.7
vs History
43
vs Industry
21
Median 3Y
13.5
Median 5Y
11.6
Industry
18.9
More Details
17.8
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
17.8
vs History
36
vs Industry
19
Median 3Y
18.6
Median 5Y
14.1
Industry
24.1
More Details
14.1
EV/OCF
EV/OCF
Enterprise Value to OCF
14.1
vs History
29
vs Industry
25
Median 3Y
12.2
Median 5Y
8.5
Industry
20.3
More Details
30.4
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
30.4
vs History
36
vs Industry
11
Median 3Y
32.3
Median 5Y
13.3
Industry
26.9
More Details
3.7
EV/IC
EV/IC
Enterprise Value to IC
3.7
vs History
34
vs Industry
18
Median 3Y
3.9
Median 5Y
2.4
Industry
2.3
More Details

Multiples Across Competitors

WINDLAS Competitors Multiples
Windlas Biotech Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IN
Windlas Biotech Ltd
NSE:WINDLAS
15.9B INR 1.9 23.7 12.7 17.8
US
PerkinElmer Inc
LSE:0KHE
1.1T USD 402.1 4 763.8 1 397.1 2 806.8
US
Thermo Fisher Scientific Inc
NYSE:TMO
229B USD 5.2 34.9 24.7 32
US
Danaher Corp
NYSE:DHR
166B USD 6.8 47.4 25.4 38.4
CH
Lonza Group AG
SIX:LONN
37.6B CHF 5.3 51.3 39.1 39.1
US
Agilent Technologies Inc
NYSE:A
41.3B USD 5.9 31.7 24.5 29.2
US
IQVIA Holdings Inc
NYSE:IQV
41.4B USD 2.6 32.3 15.4 23.1
CN
WuXi AppTec Co Ltd
SSE:603259
280.8B CNY 6.3 18.7 21.3 21.3
KR
Samsung Biologics Co Ltd
KRX:207940
46.3T KRW 8.4 29 16.9 22.5
US
Mettler-Toledo International Inc
NYSE:MTD
29.9B USD 7.6 35.8 25.8 28.6
FR
Sartorius Stedim Biotech SA
PAR:DIM
20.8B EUR 7.1 79.2 27.9 45.9

See Also

Summary
WINDLAS intrinsic value, competitors valuation, and company profile.
DCF Valuation
WINDLAS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
WINDLAS stock valuation using valuation multiples.
Wall Street Estimates
WINDLAS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
WINDLAS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 308,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.